We report the final optical identifications of the medium-depth (∼60 ks), contiguous (2 deg 2 ) XMM-Newton survey of the COSMOS field. XMM - Newton has detected ∼1800 X-ray sources down to limiting fluxes of ∼5 × 10 −16 , ∼3 × 10 −15 , and ∼7 × 10 −15 erg cm −2 s −1 in the 0.5–2 keV, 2–10 keV, and 5–10 keV bands, respectively (∼1 × 10 −15 , ∼6 × 10 −15 , and ∼1 × 10 −14 erg cm −2 s −1 , in the three bands, respectively, over 50% of the area). The work is complemented by an extensive collection of multiwavelength data from 24 μm to UV, available from the COSMOS survey, for each of the X-ray sources, including spectroscopic redshifts for ≳50% of the sample, and high-quality photometric redshifts for the rest. The XMM and multiwavelength flux limits are well matched: 1760 (98%) of the X-ray sources have optical counterparts, 1711 (∼95%) have IRAC counterparts, and 1394 (∼78%) have MIPS 24 μm detections. Thanks to the redshift completeness (almost 100%) we were able to constrain the high-luminosity tail of the X-ray luminosity function confirming that the peak of the number density of log L X > 44.5 active galactic nuclei (AGNs) is at z ∼ 2. Spectroscopically identified obscured and unobscured AGNs, as well as normal and star-forming galaxies, present well-defined optical and infrared properties. We devised a robust method to identify a sample of ∼150 high-redshift ( z > 1), obscured AGN candidates for which optical spectroscopy is not available. We were able to determine that the fraction of the obscured AGN population at the highest ( L X > 10 44 erg s −1 ) X-ray luminosity is ∼15%–30% when selection effects are taken into account, providing an important observational constraint for X-ray background synthesis. We studied in detail the optical spectrum and the overall spectral energy distribution of a prototypical Type 2 QSO, caught in a stage transitioning from being starburst dominated to AGN dominated, which was possible to isolate only thanks to the combination of X-ray and infrared observations.
No takes yet. Share an insight, caveat, or question.
A 2010 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: